NCT01293019 Osteopathic Treatment in Adult Patients With Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT01288170 Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® Status UNKNOWN Phase NA
NCT01285895 Needs in Education for Pulmonary or Cardiopulmonary Transplanted Cystic Fibrosis Patients Status COMPLETED Phase N/A
NCT01285882 Representations of Transplantation in Patients and in Health Care Professionals Status COMPLETED Phase N/A
NCT01270347 Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients Status COMPLETED Phase PHASE3
NCT01270074 Prevention of Bronchiectasis in Infants With Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT01266473 Study of Individualized Physiotherapy for Airway Clearance in Cystic Fibrosis. Status COMPLETED Phase NA
NCT01262352 Study of the Effect of Ivacaftor on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation Status COMPLETED Phase PHASE2
NCT01241942 Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability Status TERMINATED Phase NA
NCT01238081 The Role of Respiratory Viruses in Exacerbations of Cystic Fibrosis in Adults Status COMPLETED Phase N/A
NCT01229553 Effect of Topical and Systemic Decolonization of Staphylococcus Aureus (SA) in Pediatric Cystic Fibrosis (CF) Patients Status WITHDRAWN Phase NA
NCT01225211 Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation Status COMPLETED Phase PHASE2
NCT01223183 Absorptive Clearance After Inhaled Osmotics in Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT01222273 Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis Status COMPLETED Phase NA
NCT01216046 Drug-Drug Interaction Study of VX-770 and VX-809 in Healthy Subjects Status COMPLETED Phase PHASE1